New England Journal of Medicine · 2020 · 108 citations · 13 references
MedicineMolecular GeneticsPediatricsImmunopathologyInflammationNeonatologyInflammatory SignalingInnate Immune ActivationInnate Immune ResponseInnate Immune Signaling PathwaysInterferon ResponsesNeonatal ImmunologyHomozygous Lethal MutationsInterferon Pathway DefectsInterferon Pathway GenesInterferon Receptor SignalingJak Inhibitor TherapyJanus Kinase Inhibitor TherapySustained RecoveryType I Interferon Pathways
. The encoded protein was expressed but devoid of negative regulatory ability. Treatment with ruxolitinib was followed by a prompt and sustained recovery. (Funded by King Saud University and others.).
13
The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies
Aziz Bousfiha, Leïla Jeddane, Capucine Pïcard et al. · Journal of Clinical Immunology · 2017 · 517 citations · Full text